All In Biotech

Drug Trial Radar · NCT04442503

A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)

A Randomized, Double-Blind, Placebo-controlled Study Evaluating the Efficacy and Safety of SAGE-217 in the Treatment of Adults With Severe Postpartum Depression

Last checked: Nov 20, 2026Latest source record: Nov 30, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

200

Actual

Start

Jun 8, 2020

Primary completion

Mar 15, 2022

Study completion Apr 12, 2022

Sponsor

Lead sponsor
BiogenBiogen (BIIB)
Sponsor type
Industry
First posted
Jun 22, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if treatment with SAGE-217 reduces depressive symptoms in females with severe postpartum depression (PPD) as compared to placebo.

Conditions

  • Depression, Postpartum

Interventions

  • SAGE-217Drug

    SAGE-217 oral capsules.

  • PlaceboDrug

    SAGE-217 matched-placebo oral capsules.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline (CFB) in the 17-item Hamilton Rating Scale for Depression (HAM-D) Total Score at Day 15Time frame: Baseline and Day 15

Locations

82 sites in 3 countries. Site status is shown where the registry gives one.

  • Sage Investigational Site

    Scottsdale, Arizona

  • Sage Investigational Site

    Bentonville, Arkansas

  • Sage Investigational Site

    Anaheim, California

  • Sage Investigational Site

    Bellflower, California

  • Sage Investigational Site

    Beverly Hills, California

  • Sage Investigational Site

    Costa Mesa, California

  • Sage Investigational Site

    Imperial, California

  • Sage Investigational Site

    Lemon Grove, California

  • Sage Investigational Site

    Norwalk, California

  • Sage Investigational Site

    Oceanside, California

  • Sage Investigational Site

    Orange, California

  • Sage Investigational Site

    Orange, California

  • Sage Investigational Site

    Redlands, California

  • Sage Investigational Site

    San Bernardino, California

  • Sage Investigational Site

    Sherman Oaks, California

  • Sage Investigational Site

    Torrance, California

  • Sage Investigational Site

    Aurora, Colorado

  • Sage Investigational Site

    Norwich, Connecticut

  • Sage Investigational Site

    Boynton Beach, Florida

  • Sage Investigational Site

    Hialeah, Florida

  • Sage Investigational Site

    Jacksonville, Florida

  • Sage Investigational Site

    Miami, Florida

  • Sage Investigational Site

    Miami Springs, Florida

  • Sage Investigational Site

    Miramar, Florida

  • Sage Investigational Site

    Orlando, Florida

  • Sage Investigational Site

    Orlando, Florida

  • Sage Investigational Site

    Pensacola, Florida

  • Sage Investigational Site

    Pinellas Park, Florida

  • Sage Investigational Site

    Pompano Beach, Florida

  • Sage Investigational Site

    Alpharetta, Georgia

  • Sage Investigational Site

    Atlanta, Georgia

  • Sage Investigational Site

    Decatur, Georgia

  • Sage Investigational Site

    Savannah, Georgia

  • Sage Investigational Site

    Idaho Falls, Idaho

  • Sage Investigational Site

    Hoffman Estates, Illinois

  • Sage Investigational Site

    Lincolnwood, Illinois

  • Sage Investigational Site

    Wichita, Kansas

  • Sage Investigational Site

    New Orleans, Louisiana

  • Sage Investigational Site

    Boston, Massachusetts

  • Sage Investigational Site

    Detroit, Michigan

Showing 40 of 82 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.